Selected article for: "comparative study and large study"
Author: Lee, Eun Sil
Title: A Flood of Health Functional Foods: What Is to Be Recommended?
  • Document date: 2015_4_27
    • ID: thkzoirr_17
    Snippet: The GAIT study presented in 2006 is a large scale comparative study that firstly compared the effects of glucosamine, chondroitin, glucosamine+chondroitin, cyclooxygenase inhibitor and placebo. 39 A total of 1583 patients were followed for 6 months, and a 20% relative reduction for each primary endpoint of WOMAC score was observed. In conclusion, the use of glucosamine alone or combination of glucosamine and chondroitin for 6 months did not relie.....
    Document: The GAIT study presented in 2006 is a large scale comparative study that firstly compared the effects of glucosamine, chondroitin, glucosamine+chondroitin, cyclooxygenase inhibitor and placebo. 39 A total of 1583 patients were followed for 6 months, and a 20% relative reduction for each primary endpoint of WOMAC score was observed. In conclusion, the use of glucosamine alone or combination of glucosamine and chondroitin for 6 months did not relieve pain in patients with osteoarthritis of the knee, and showed the same outcome of placebo.

    Search related documents:
    Co phrase search for related documents
    • comparative study and large scale: 1, 2, 3, 4, 5, 6, 7, 8
    • comparative study and primary endpoint: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • comparative study and relative reduction: 1, 2, 3
    • knee osteoarthritis and pain relieve: 1, 2
    • knee osteoarthritis and primary endpoint: 1
    • knee osteoarthritis and WOMAC score: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • large scale and pain relieve: 1
    • large scale and placebo outcome: 1
    • large scale and primary endpoint: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
    • large scale and relative reduction: 1, 2, 3
    • pain relieve and primary endpoint: 1
    • pain relieve and relative reduction: 1
    • placebo outcome and primary endpoint: 1, 2, 3, 4, 5, 6
    • placebo outcome and relative reduction: 1, 2
    • placebo outcome and WOMAC score: 1
    • primary endpoint and relative reduction: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • primary endpoint and WOMAC score: 1